Compounds > cadmium chloride
Page last updated: 2024-08-22

cadmium chloride and Ovarian Neoplasms

cadmium chloride has been researched along with Ovarian Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aghaei, M; Ataei, N; Panjehpour, M1
Barnard, CF; Harrap, KR; Kelland, LR; Mellish, KJ1
Rehm, S; Waalkes, MP1
Abe, T; Gotoh, S; Higashi, K1
Abel, G; Freidlos, F; Harrap, KR; Kelland, LR; Loh, SY; Mistry, P; Roberts, JJ1
Andrews, PA; Zinkewich-Péotti, K1

Other Studies

6 other study(ies) available for cadmium chloride and Ovarian Neoplasms

ArticleYear
Evidences for involvement of estrogen receptor induced ERK1/2 activation in ovarian cancer cell proliferation by Cadmium Chloride.
    Toxicology in vitro : an international journal published in association with BIBRA, 2019, Volume: 56

    Topics: Cadmium Chloride; Carcinogens; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; Forkhead Box Protein O3; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Estrogen

2019
Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)].
    International journal of cancer, 1994, Oct-01, Volume: 59, Issue:1

    Topics: Antineoplastic Agents; Cadmium; Cadmium Chloride; Chlorides; Cross-Linking Reagents; DNA, Neoplasm; Drug Resistance; Female; Glutathione; Humans; Metallothionein; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured

1994
Lack of carcinogenicity of cadmium chloride in female Syrian hamsters.
    Toxicology, 1998, Apr-03, Volume: 126, Issue:3

    Topics: Amyloidosis; Animals; Body Weight; Cadmium Chloride; Carcinogens; Cricetinae; Dose-Response Relationship, Drug; Estrus; Female; Injections, Subcutaneous; Liver; Mesocricetus; Necrosis; Ovarian Neoplasms; Ovary; Pancreas

1998
Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells.
    Biochemical pharmacology, 1999, Jul-01, Volume: 58, Issue:1

    Topics: Acetylcysteine; Cadmium Chloride; Cisplatin; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Free Radical Scavengers; Gene Expression; Glutathione; Heat Shock Transcription Factors; Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Mutagens; Ovarian Neoplasms; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured

1999
Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Cancer research, 1992, Apr-01, Volume: 52, Issue:7

    Topics: Antineoplastic Agents; Cadmium; Cadmium Chloride; Cell Line; Cell Survival; Cisplatin; DNA, Neoplasm; Drug Resistance; Female; Glutathione; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Testicular Neoplasms; Uterine Cervical Neoplasms

1992
Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance.
    Cancer research, 1992, Apr-01, Volume: 52, Issue:7

    Topics: Cadmium; Cadmium Chloride; Cell Line; Cisplatin; Doxorubicin; Drug Resistance; Female; Flow Cytometry; Fluorescent Dyes; Glutathione; Humans; Kinetics; Onium Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Rhodamine 123; Rhodamines

1992